Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Velocity Clinical Research- East Syracuse, New York

Verified

Basic Information

Site Overview

Source: Human-provided.

Velocity’s research site in Syracuse was founded in 2017 as Clarity Clinical Research and acquired by Velocity in 2021. Our Syracuse site offers expertise in diabetes, NASH, vaccine, and neurology trials. All trials conducted at the site are performed in accordance with ICH and FDA guidelines, and in compliance with GCP. Our experienced staff maintains the highest standard of quality and patient care on all their trials. Conveniently located on the intersection of major local highways, Velocity Syracuse is one of only a few research sites in the Central New York area. The site has ample parking available for patients. The local hospital is 2 miles away from the research site. The Syracuse team is committed to being a resource for study volunteers, to providing the highest quality of patient care with compassion and kindness and to advancing medicine through research.

Business Status

Source: Google. OPEN

Business Category

Source: Google. Research institute

Business Subcategory

Source: Google. Research institute
Source: Trial-derived.
16Total Trials
Source: Trial-derived.
3Recruiting Trials
Source: Trial-derived.
8Active Trials
Source: Trial-derived.
8Completed Trials
Source: Trial-derived.
49Unique Conditions
Source: Trial-derived.
13Unique Sponsors

Affiliations

Conditions

Source: Trial-derived. Alzheimer Disease (4)Source: Trial-derived. Mild Cognitive Impairment (4)Source: Trial-derived. Diabetic Peripheral Neuropathic Pain (3)Source: Trial-derived. Alzheimer Disease, Early Onset (2)Source: Trial-derived. Cognitive Impairment (2)Source: Trial-derived. Dementia Alzheimers (2)Source: Trial-derived. Dementia, Mild (2)Source: Trial-derived. Dementia Moderate (2)

Sponsors

Source: Trial-derived. Vertex Pharmaceuticals Incorporated (3)Source: Trial-derived. Cognito Therapeutics, Inc. (2)Source: Trial-derived. ModernaTX, Inc. (2)Source: Trial-derived. Novo Nordisk A/S (2)Source: Trial-derived. Seqirus (2)Source: Trial-derived. Alzheimer's Therapeutic Research Institute (1)Source: Trial-derived. CinDome Pharma, Inc. (1)Source: Trial-derived. GAP Innovations, PBC (1)

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Electronic data capture

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Continuous glucose monitoring

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical microbiology culture
Source: AI-inferred. PCR / molecular
Source: AI-inferred. Clinical laboratory testing

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Blood glucose meter monitoring
Source: AI-inferred. Electronic participant diary (eDiary) system
Source: AI-inferred. Hemagglutination inhibition (HAI) antibody assay
Source: AI-inferred. Hemagglutination inhibition (HI) serology assay
Source: AI-inferred. Ophthalmologic examination
Source: AI-inferred. Ophthalmological retinopathy examination